psychedelics investing Compass Pathways to Participate in Jefferies Global Healthcare Conference on November 18th and 19th 11 November
psychedelics investing Compass Pathways Completes COMP360 Psilocybin New Drug Application to U.S. FDA for Treatment-Resistant Depression 09 November
psychedelics investing Compass Pathways to Participate in Stifel 2026 Healthcare Conference on November 11th 04 November
